Asset
Opakalim
Revenue
No revenue reported in loaded filings.
Clinical trials (9)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07262268 | phase1 | enrolling_by_invitation | 2026-01-15 | 2026-11-01 | Biohaven Therapeutics Ltd. | A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia |
| NCT06425159 | phase2_3 | terminated | 2024-06-20 | 2026-03-12 | Biohaven Therapeutics Ltd. | A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures |
| NCT06132893 | phase2_3 | recruiting | 2024-03-14 | 2026-12-01 | Biohaven Therapeutics Ltd. | A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy |
| NCT06419582 | phase2_3 | completed | 2024-05-28 | 2025-01-15 | Biohaven Therapeutics Ltd. | BHV-7000 Acute Treatment of Bipolar Mania |
| NCT06423794 | phase2 | terminated | 2024-06-24 | 2025-04-25 | Biohaven Therapeutics Ltd. | BHV-7000 Open-Label Extension Bipolar Mania Study |
FDA applications (0)
This company has no applications containing this asset.